Core Points - Novavax, Inc. will report its second quarter 2025 financial results and operational highlights on August 6, 2025, at 8:30 a.m. ET [1] - The company utilizes a scientific expertise in vaccines and a proven technology platform, including protein-based nanoparticles and Matrix-M® adjuvant [2] - Novavax's growth strategy focuses on optimizing existing partnerships, expanding access to its technology platform, and fostering new collaborations [2] Conference Call Details - The conference call is scheduled for August 6, 2025, at 8:30 a.m. U.S. ET, with a registration link provided for participants [1] - A replay of the call will be available starting at 11:30 a.m. U.S. ET on the same day until August 13, 2025 [2] - Participants can join the call via a direct dial or by registering online for an automated callback [4]
Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025